2.2.0.25falsefalse04090 - Disclosure - Reinsurance (Details)truefalsefalse1falsefalseUSDfalsefalse10/1/2010 - 12/31/2010 USD ($) USD ($) / shares $FROM_Oct01_2010_TO_Dec31_2010http://www.sec.gov/CIK0000911421duration2010-10-01T00:00:002010-12-31T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170EPSDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2falsefalseUSDfalsefalse7/1/2010 - 9/30/2010 USD ($) USD ($) / shares $FROM_Jul01_2010_TO_Sep30_2010http://www.sec.gov/CIK0000911421duration2010-07-01T00:00:002010-09-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170EPSDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$3falsefalseUSDfalsefalse4/1/2010 - 6/30/2010 USD ($) USD ($) / shares $FROM_Apr01_2010_TO_Jun30_2010http://www.sec.gov/CIK0000911421duration2010-04-01T00:00:002010-06-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170EPSDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$4falsefalseUSDfalsefalse1/1/2010 - 3/31/2010 USD ($) USD ($) / shares $FROM_Jan01_2010_TO_Mar31_2010http://www.sec.gov/CIK0000911421duration2010-01-01T00:00:002010-03-31T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170EPSDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$5falsefalseUSDfalsefalse10/1/2009 - 12/31/2009 USD ($) / shares USD ($) $FROM_Oct01_2009_TO_Dec31_2009http://www.sec.gov/CIK0000911421duration2009-10-01T00:00:002009-12-31T00:00:00EPSDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$6falsefalseUSDfalsefalse7/1/2009 - 9/30/2009 USD ($) USD ($) / shares $FROM_Jul01_2009_TO_Sep30_2009http://www.sec.gov/CIK0000911421duration2009-07-01T00:00:002009-09-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170EPSDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$7falsefalseUSDfalsefalse4/1/2009 - 6/30/2009 USD ($) USD ($) / shares $FROM_Apr01_2009_TO_Jun30_2009http://www.sec.gov/CIK0000911421duration2009-04-01T00:00:002009-06-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170EPSDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$8falsefalseUSDfalsefalse1/1/2009 - 3/31/2009 USD ($) USD ($) / shares $FROM_Jan01_2009_TO_Mar31_2009http://www.sec.gov/CIK0000911421duration2009-01-01T00:00:002009-03-31T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170EPSDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$9falsefalseUSDfalsefalse1/1/2010 - 12/31/2010 USD ($) USD ($) / shares $FROM_Jan01_2010_TO_Dec31_2010http://www.sec.gov/CIK0000911421duration2010-01-01T00:00:002010-12-31T00:00:00SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0EPSDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$10falsefalseUSDfalsefalse1/1/2009 - 12/31/2009 USD ($) USD ($) / shares $FROM_Jan01_2009_TO_Dec31_2009http://www.sec.gov/CIK0000911421duration2009-01-01T00:00:002009-12-31T00:00:00PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170EPSDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$11falsefalseUSDfalsefalse1/1/2008 - 12/31/2008 USD ($) $FROM_Jan01_2008_TO_Dec31_2008http://www.sec.gov/CIK0000911421duration2008-01-01T00:00:002008-12-31T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170PureStandardhttp://www.xbrl.org/2003/instancepurexbrli0SharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$12falsefalsefalsefalse1/1/2007 - 12/31/2007 FROM_Jan01_2007_TO_Dec31_2007http://www.sec.gov/CIK0000911421duration2007-01-01T00:00:002007-12-31T00:00:00PureStandardhttp://www.xbrl.org/2003/instancepurexbrli03true0pre_ReinsuranceRecoverableOnPaidAndUnpaidLossesAbstractprefalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9falsefalsefalse00falsefalsefalsefalsefalse10falsefalsefalse00falsefalsefalsefalsefalse11falsefalsefalse00falsefalsefalsefalsefalse12falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseReinsurance Recoverable On Paid And Unpaid Losses [Abstract]4false0pre_AllowanceForUncollectibleReinsuranceRecoverableprefalsecreditinstantA valuation allowance for the amount deemed uncollectible from reinsurers.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse69000006900000falsetruefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5truefalsefalse68000006800000falsetruefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9truefalsefalse69000006900000falsetruefalsefalsefalse10truefalsefalse68000006800000falsetruefalsefalsefalse11falsefalsefalse00falsefalsefalsefalsefalse12falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryA valuation allowance for the amount deemed uncollectible from reinsurers.No authoritative reference available.falsefalseAllowance For Uncollectible Reinsurance Recoverable5false0pre_ReinsuranceBalancesRecoverableprefalsedebitinstantReinsurance balances receivable under quota share arrangement. The counterparty's obligations are collateralized by cash and...falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse1680000016800000falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5truefalsefalse2840000028400000falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9truefalsefalse1680000016800000falsefalsefalsefalsefalse10truefalsefalse2840000028400000falsefalsefalsefalsefalse11falsefalsefalse00falsefalsefalsefalsefalse12falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryReinsurance balances receivable under quota share arrangement. The counterparty's obligations are collateralized by cash and other liquid assets held in a trust which includes that company's capital and premiums.No authoritative reference available.falsefalseReinsurance Balances Recoverable6false0pre_CapitalizationOfQuotaShareCounterpartyprefalsecreditinstantApproximate amount of capitalization of counterparty to collateralized quota share agreement.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse1900000019000000falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5truefalsefalse3300000033000000falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9truefalsefalse1900000019000000falsefalsefalsefalsefalse10truefalsefalse3300000033000000falsefalsefalsefalsefalse11falsefalsefalse00falsefalsefalsefalsefalse12falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryApproximate amount of capitalization of counterparty to collateralized quota share agreement.No authoritative reference available.falsefalseCapitalization Of Quota Share Counterparty7false0pre_QuotaShareTreatyPercentageprefalsenadurationQuota share treaty percentage with a special purpose reinsurance company.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsetruefalse00falsefalsefalsefalsefalse2falsetruefalse00falsefalsefalsefalsefalse3falsetruefalse00falsefalsefalsefalsefalse4falsetruefalse00falsefalsefalsefalsefalse5falsetruefalse00falsefalsefalsefalsefalse6falsetruefalse00falsefalsefalsefalsefalse7falsetruefalse00falsefalsefalsefalsefalse8falsetruefalse00falsefalsefalsefalsefalse9falsetruefalse00falsefalsefalsefalsefalse10falsetruefalse00falsefalsefalsefalsefalse11truetruefalse0.240.24falsefalsefalsefalsefalse12truetruefalse0.240.24falsefalsefalsefalsefalseOtherus-types:percentItemTypepureQuota share treaty percentage with a special purpose reinsurance company.No authoritative reference available.falsefalseQuota Share Treaty Percentage9true0us-gaap_PremiumsWrittenNetConsolidatedAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9falsefalsefalse00falsefalsefalsefalsefalse10falsefalsefalse00falsefalsefalsefalsefalse11falsefalsefalse00falsefalsefalsefalsefalse12falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalsePremiums written10false0us-gaap_AssumedPremiumsWrittenus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9truefalsefalse48852660004885266000falsefalsefalsefalsefalse10truefalsefalse40008880004000888000falsefalsefalsefalsefalse11truefalsefalse40282480004028248000falsefalsefalsefalsefalse12falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryPremiums for all insurance assumed from other insurers, that is premiums ceded to the entity by other insurers.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 113 -Paragraph 27 -Subparagraph a, b falsefalseAssumed11false0us-gaap_CededPremiumsWrittenus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9truefalsefalse180150000180150000falsefalsefalsefalsefalse10truefalsefalse5218400052184000falsefalsefalsefalsefalse11truefalsefalse3881300038813000falsefalsefalsefalsefalse12falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryTotal consideration paid and payable to reinsurers during the period pursuant to terms of reinsurance arrangements.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 17 -Article 12 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 113 -Paragraph 27 -Subparagraph a, b falsefalseCeded12false0us-gaap_PremiumsWrittenNetus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1truefalsefalse820600000820600000falsefalsefalsefalsefalse2truefalsefalse987600000987600000falsefalsefalsefalsefalse3truefalsefalse11127000001112700000falsefalsefalsefalsefalse4truefalsefalse17842000001784200000falsefalsefalsefalsefalse5truefalsefalse904400000904400000falsefalsefalsefalsefalse6truefalsefalse891500000891500000falsefalsefalsefalsefalse7truefalsefalse844700000844700000falsefalsefalsefalsefalse8truefalsefalse13081000001308100000falsefalsefalsefalsefalse9truefalsefalse47051160004705116000falsefalsefalsefalsefalse10truefalsefalse39487040003948704000falsefalsefalsefalsefalse11truefalsefalse39894350003989435000falsefalsefalsefalsefalse12falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryPremiums written for all insurance and reinsurance contracts, after adding premiums assumed from other insurers and subtracting any amounts ceded to another insurer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 17 -Article 12 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 113 -Paragraph 27 -Subparagraph a, b falsefalseNet13true0pre_PremiumsEarnedNetConsolidatedAbstractprefalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9falsefalsefalse00falsefalsefalsefalsefalse10falsefalsefalse00falsefalsefalsefalsefalse11falsefalsefalse00falsefalsefalsefalsefalse12falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalsePremiums Earned Net Consolidated Abstract14false0pre_AssumedPremiumsEarnedprefalsecreditdurationPremiums earned for all reinsurance assumed from other insurers as a result of reinsurance arrangements.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9truefalsefalse49568970004956897000falsefalsefalsefalsefalse10truefalsefalse42023790004202379000falsefalsefalsefalsefalse11truefalsefalse39677040003967704000falsefalsefalsefalsefalse12falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryPremiums earned for all reinsurance assumed from other insurers as a result of reinsurance arrangements.No authoritative reference available.falsefalseAssumed15false0pre_CededPremiumsEarnedprefalsedebitdurationPremiums ceded to other insurers as a result of ceded reinsurance arrangements.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9truefalsefalse180426000180426000falsefalsefalsefalsefalse10truefalsefalse8255400082554000falsefalsefalsefalsefalse11truefalsefalse3968000039680000falsefalsefalsefalsefalse12falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryPremiums ceded to other insurers as a result of ceded reinsurance arrangements.No authoritative reference available.falsefalseCeded16false0us-gaap_PremiumsEarnedNetus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse12046000001204600000falsefalsefalsefalsefalse2truefalsefalse13134000001313400000falsefalsefalsefalsefalse3truefalsefalse11046000001104600000falsefalsefalsefalsefalse4truefalsefalse11538000001153800000falsefalsefalsefalsefalse5truefalsefalse13366000001336600000falsefalsefalsefalsefalse6truefalsefalse10907000001090700000falsefalsefalsefalsefalse7truefalsefalse826100000826100000falsefalsefalsefalsefalse8truefalsefalse866500000866500000falsefalsefalsefalsefalse9truefalsefalse47764710004776471000falsefalsefalsefalsefalse10truefalsefalse41198250004119825000falsefalsefalsefalsefalse11truefalsefalse39280240003928024000falsefalsefalsefalsefalse12falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryPremiums earned on the income statement for all insurance and reinsurance contracts after subtracting any amounts ceded to another insurer and adding premiums assumed from other insurers.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 1 -Article 7 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Statement of Financial Accounting Standard (FAS) -Number 113 -Paragraph 27 -Subparagraph a, b falsefalseNet17true0us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9falsefalsefalse00falsefalsefalsefalsefalse10falsefalsefalse00falsefalsefalsefalsefalse11falsefalsefalse00falsefalsefalsefalsefalse12falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseLoss and Loss Expenses and Life Policy Benefits18false0us-gaap_PolicyholderBenefitsAndClaimsIncurredGrossus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9truefalsefalse33991570003399157000falsefalsefalsefalsefalse10truefalsefalse23139510002313951000falsefalsefalsefalsefalse11truefalsefalse26134340002613434000falsefalsefalsefalsefalse12falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryTotal provision in the period for future policy benefits, claims incurred and costs incurred in the claims settlement process before the effects of reinsurance arrangements.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 5 -Article 7 falsefalseAssumed19false0us-gaap_ReinsuranceCostsAndRecoveriesNetus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9truefalsefalse115539000115539000falsefalsefalsefalsefalse10truefalsefalse1865500018655000falsefalsefalsefalsefalse11truefalsefalse42140004214000falsefalsefalsefalsefalse12falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe net amount in the period for future policy benefits and costs incurred under policies assumed and estimated recoupments under policies ceded.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher AICPA -Name Statement of Position (SOP) -Number 94-5 -Paragraph 11 falsefalseCeded20false0us-gaap_PolicyholderBenefitsAndClaimsIncurredNetus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse817800000817800000falsetruefalsefalsefalse2truefalsefalse748900000748900000falsetruefalsefalsefalse3truefalsefalse704600000704600000falsetruefalsefalsefalse4truefalsefalse10124000001012400000falsetruefalsefalsefalse5truefalsefalse743300000743300000falsetruefalsefalsefalse6truefalsefalse574200000574200000falsetruefalsefalsefalse7truefalsefalse458900000458900000falsetruefalsefalsefalse8truefalsefalse518900000518900000falsetruefalsefalsefalse9truefalsefalse32836180003283618000falsetruefalsefalsefalse10truefalsefalse22952960002295296000falsetruefalsefalsefalse11truefalsefalse26092200002609220000falsetruefalsefalsefalse12falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryProvision for benefits, claims and claims settlement expenses incurred during the period net of the effects of contracts assumed and ceded.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 5 -Article 7 falsefalseLosses and loss expenses and life policy benefits1217Reinsurance (Details) (USD $)NoRoundingUnKnownUnKnownUnKnowntruetrue